TABLE 1.
Patient demographics with EORTC-MSG diagnosis of IAa
| Demographicb | Proven/probable IA (n = 19) | NEF (n = 42)c |
|---|---|---|
| No. of males/no. of females | 13/6 | 25/17 |
| Age (mean [range]) (yr) | 52.2 (24–73) | 52.5 (21–78) |
| Underlying condition (no.) | ||
| AML/MDS | 12 | 22 |
| Lymphoma | 4 | 5 |
| Myeloma | 6 | |
| ALL | 1 | 2 |
| AA | 1 | 1 |
| CML/CLL | 1 | 4 |
| Other | 2d | |
| IPA (no.) | 15 | None |
| IPA/sinusitis (no.) | 4 |
a
IA, invasive aspergillosis.
b
AML, acute myeloid leukemia; MDS, myelodysplastic syndrome; ALL, acute lymphoblastic leukemia; AA, aplastic anemia; CLL, chronic lymphoblastic leukemia; CML, chronic myeloid leukemia; IPA, invasive pulmonary aspergillosis. Lymphoma comprises Hodgkin, non-Hodgkin lymphoma and diffuse large B-cell lymphoma.
c
NEF, no evidence of fungal disease (control population).
d
Includes one case of myelofibrosis and one case of combined immunodeficiency with lymphoproliferation.